FIGURE LEGENDS, SUPPLEMENT:
Fig. S1. (a) The addition of 0.4% (wt/vol) activated charcoal to 7H9-glycerol liquid medium prior to autoclaving decolorizes the medium. (b) Evidence that activated charcoal binds Alamar blue in solution. Stationary-phase Msm in 7H9-glycerol liquid medium (200 µL) at an OD580 of 0.5 was mixed with 0 -0.4% activated charcoal in a 96-well plate. Alamar blue:Tween 80 (in PBS) (1:1) (40 µL) was added, and fluorescence allowed to develop, during 1 hour at room temperature. Data are means +/-standard deviation of quadruplicate wells. In some cases, error bars are obscured by data points. This is one of 3 experiments with similar results. Colonies arising from 10-fold serial dilutions of wild-type Mtb were observed at similar times when grown on (c) 7H11-OADC agar or (d) 7H11-OADC agar supplemented with 0.4% activated charcoal. Colonies were often smaller on 7H11-OADC-charcoal plates. can then be compared with the standard liquid broth MIC to generate a hypothesis as to whether a replicating-active compound is bactericidal (a) or bacteriostatic (b-d) . For some compounds, bacteriostasis requires the identification of a static window (SW) (d) that emerges as a > 4-fold shift between the MIC and CARA-MBC≥99. The example shown in (e) demonstrates a candidate non-replicating-active molecule whose NR-CARA suggests activity only at the highest drug concentrations tested; however, this can often be artefactual. In (f), a compound may exhibit higher potency by the CARA compared with the MIC90 assay, although such cases are rare. The example in (g) demonstrates an application of the CARA to identify compounds with pure replicating activity and no non-replicating activity. In general, MIC to CARA-MBC≥99 differences of 2-fold or lower are likely due to experimental variability. The data are hypothetical. Table S1 . Evidence that TMC207 and PA824 are carried over at growth inhibitory concentrations from liquid broth assays to 7H11-OADC agar plates, and inclusion of activated charcoal in the agar plates can mitigate this effect.
Data presented are colony counts from replicating wild-type Mtb exposed to 30 µg/mL TMC207 and PA824 for 7 days. Results of triplicates are separated by commas. 10 L were removed from a 200 L assay volume from a liquid MIC assay plate in 96-well format and spread on a 7H11-OADC agar plate with or without 0.4% activated charcoal, directly (undiluted) or diluted 10-or 100-fold in 7H9-ADN medium prior to plating 10 L. Each aliquot of 10 L was spread onto 8 mL of 7H11-OADC agar in a Y-style petri plate, effectively diluting any residual drug 800-fold to 0.038 g/mL. Similar trends, albeit less dramatic, were observed at 10 µg/mL for both drugs (data not shown). Representative bacterial counts of one experiment performed 4 times. Table S2 . Physicochemical properties of anti-Mycobacterial molecules. The data in the column, "% removed by 0.4% (wt/vol) activated charcoal", was reproduced from Table 2 to facilitate data analysis.
